Johnson & Johnson (NYSE: JNJ) is an elite dividend stock. The healthcare giant has increased its dividend payment for 62 years in a row. The iconic healthcare company backs its high-yielding payout with a very healthy financial profile.

A quarterly dividend payment from a high-quality stock may be as close to a sure thing as an investor can find on Wall Street. Even during periods of broad market weakness, the lower a stock's price falls,

Dividend stocks can be enriching investments. They supply income and have historically produced higher total returns than non-payers. With the stock market rallying last year, div

The Dow Jones Industrial Average, or simply the Dow, is one of the most well-known and influential stock market indices globally.

The same is true for stocks. Consider that global icon Apple Inc. (ticker: AAPL) yields a mere 0.4%, despite having roughly $100 billion in net income and one of the most entrenched brands in the planet. That's because it's easy to maintain a nominal dividend, but much harder to drive a huge yield – even for titans like Apple.

Many dividend stocks lost their luster in 2022 and 2023 as rising interest rates drove jittery investors toward safer CDs, Treasury bills, and other fixed-income investments. However, many of those high-yielding dividend stocks stabilized in 2024 as the Federal Reserve finally implemented three interest rate cuts.